[Combined therapy for 121 cases of advanced cancer of the maxillary sinus].
OBJECTIVE
To investigate the possibility of combined therapy (chemotherapy + surgery) for advanced cancer of maxillary sinus.


METHODS
Pre-operative radiation + surgery for 61 cases and preoperative chemotherapy + operation for 60 cases were performed. Radiotherapy referred to the use of linear accelerator and/or 60 Co with the dosage of 40-60 Gy. Chemotherapy referred to the administration of CDDP. VCR, and pingyangmycin.


RESULTS
The survival rate observed in the 61 cases treated with radiation operation was 36.1%; while the other 60 cases treated by chemotherapy + operation had a survival rate of 31.1%.


CONCLUSIONS
The better way to treat advanced cancer of the maxillary sinus is pre-operative chemotherapy + surgery. In addition, repeated application of chemotherapy can raise the effect of surgical treatment.
Li
T X
TX
Henan Tumour Hospital, Zhengzhou 450003.
Wei
L
L
Jing
G P
GP
Yu
S G
SG
D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D015996:Survival Rate; D016896:Treatment Outcome